Searched for
MODERNA STOCKS
US stocks: US market ends lower as tech stocks weigh on sentimentWall Street ended lower on Friday, with AI chip stocks experiencing a significant downturn while Moderna and other healthcare companies sur...- Serum Institute of India to manufacture Oxford Ebola vaccine backed by $8.6 million CEPI fundingSerum Institute of India will produce clinical trial doses of a new Ebola vaccine from Oxford University. This initiative is backed by fres...
- Moderna first-quarter revenue jumps on strong overseas COVID vaccine salesModerna's first-quarter revenue surpassed estimates, driven by strong international COVID-19 vaccine sales. The company forecasts lower-tha...
- Moderna stocks: MRNA shares jump in US Stock market today after pharma giant surpasses Wall Street estimatesModerna had earlier posted a loss of $2.52 per share a year earlier, while analysts expected a loss of $3.96 per share.
- US Stocks: Moderna rises on $2.25 billion settlement, clearing COVID vaccine patent dispute overhangModerna shares rose 9% on Wednesday after it settled a long-running legal battle over the technology that made its COVID-19 vaccine possibl...
- Moderna plans to lay off 10% of workforce to cut costsModerna is set to reduce its global workforce by roughly 10%, aiming for under 5,000 employees by year's end, as it accelerates cost-cuttin...
- Moderna layoffs: U.S. Pharma giant announces massive job cuts, to have less than 5,000 employees, MRNA stocks sinkModerna had said earlier this year it expects operating costs to be between $4.7 billion and $5 billion for 2027. MRNA stock, which has los...
- This Nasdaq-100 stock has gained 110,600% since its IPO and it's still a Buy heading into 2025 as per Wall Street analystsThe Nasdaq-100 is currently one of the most closely-monitored stock indexes over the past week, owing to its sudden fluctuations at the US ...
- Pfizer and Moderna stocks drop after RFK Jr.'s nomination for Health Secretary: impact on the Pharma IndustryShares of leading vaccine producers, such as Pfizer and Moderna, experienced notable drops after Robert F. Kennedy Jr. was announced as Pre...
- Moderna finds that inventing a COVID-19 vaccine was the easy partModerna shares plummeted on Thursday after it announced it would be able to supply only 700 million to 800 million vaccine doses this year,...
- Moderna COVID-19 vaccine tallies more than $4 billion in Q2 salesModerna's announcement comes after pharmaceutical giant Pfizer Inc. said its COVID-19 vaccine remained effective months after the second do...
- Moderna to join S&P 500, shares jump after hoursModerna shares rose 6% in extended trade after the announcement. The COVID-19 vaccine maker's stock has surged over 150% this year, elevati...
- Vaccination halted at all 400 sites for 18-44 age group in Delhi: Manish SisodiaSisodia said all the 400 vaccination sites for the 18-44 age group have been closed in Delhi after the vaccine stock was over, while the ce...
- Moderna raises 2021 sales forecast for COVID-19 vaccine to $19.2 billionEarlier this week, larger rival Pfizer Inc said it expects $26 billion in sales of its COVID-19 vaccine this year.
- Moderna boosting COVID-19 vaccine-making capacity, targets up to 3 billion shots in 2022"As we look forward to next year, we just see so much need for primary vaccine, we are hearing it all over the world, and also boosters," M...
- Moderna mania draws bitcoin comparisons while shorts bleedModerna jumped as much as 17% in New York Tuesday. The stock has surged about 73% and added more than $28 billion in market value over the ...
- We can stop COVID-19: Moderna vaccine success gives world more hopeTogether with Pfizer Inc's vaccine, also shown to be more than 90% effective, and pending more safety data and regulatory review, the Unite...
- Markets are already pricing a successful Moderna vaccine shotThe bar was raised for markets to rally following an announcement by Pfizer Inc. that its vaccine protected 90 per cent of Covid-19 cases i...
- Wipro founder Azim Premji is an early investor in US firm ModernaWipro founder Azim Premji is an investor in Moderna, the firm that has emerged a frontrunner for Covid vaccine.
- US drugmaker reports promising early results from COVID-19 vaccine testThe Cambridge, Massachusetts-based company said the vaccine candidate, mRNA-1273, appeared to produce an immune response in eight people wh...
Load More
